Results 221 to 230 of about 1,155,096 (237)

Nanotechnology-Based Modulation of Autoimmune Microenvironments in Sjögren's Syndrome: A Review of Mechanistic Perspectives. [PDF]

Int J Nanomedicine
Liu Y, Zheng W, Cong S, Xu F, Zhang Y, Wang D.   +5 more
europepmc   +1 more source

Comparative Safety Analysis of Targeted Synthetic and Biologic Disease‐Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis: A Nationwide Cohort Study in Japan

International Journal of Rheumatic Diseases, Volume 29, Issue 9, September 2026.
ABSTRACT Aim To compare risks of malignancy, opportunistic infections, and venous thromboembolism between the targeted synthetic disease‐modifying antirheumatic drugs (tsDMARDs) and biologic DMARDs (bDMARDs) at the 2nd and 3rd lines of therapy (LOT). Methods We conducted a cohort study using the National Database of Health Insurance Claims (2013–2021).
Shiori Nishimura, Toshitaka Hirano, Soko Setoguchi, Hiroki Matsui, Yoshinori Takeuchi, Yasushi Inoue, Yoshiya Tanaka, Kunihiro Yamaoka, Yoichi Ii, Shintaro Hiro, Masato Hoshi, Naonobu Sugiyama, Yutaka Matsuyama, Hiraku Kumamaru   +13 more
wiley   +1 more source

Gastric Antral Vascular Ectasia as an Unusual Cause of Iron Deficiency Anemia in Primary Sjögren's Syndrome. [PDF]

Int J Appl Basic Med Res
Aslam SM, Shyllesh HA, Kulkarni A, Suhail KM.   +3 more
europepmc   +1 more source

What is the incidence and clinical significance of dry eye disease in patients treated with immune checkpoint inhibitors? A systematic review and meta‐analysis of ocular immune‐related adverse events

Acta Ophthalmologica, Volume 104, Issue 6, Page e599-e614, September 2026.
Abstract Purpose Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but may cause immune‐related adverse events (irAEs), including dry eye disease (DED). This study aimed to quantify the incidence of ICI‐associated DED and to evaluate factors contributing to variability across studies.
Kai‐Yang Chen, Hoi‐Chun Chan, Chi‐Ming Chan   +2 more
wiley   +1 more source

Acute Ischemic Stroke as the Initial Presentation of Primary Sjögren's Syndrome: A Case Report. [PDF]

Cureus
Pakal YK, Gade SN, Dharap NP.
europepmc   +1 more source

The impact of systemic long‐term medications for the development of age‐related macular degeneration

Acta Ophthalmologica, Volume 104, Issue 6, Page 674-681, September 2026.
Abstract Purpose Age‐related macular degeneration (AMD) is a leading cause of central vision loss in the elderly; however, the systemic factors that modulate its incidence and progression remain unclear. We sought to determine whether long‐term use of systemic medications, including diabetes and antithrombotic medications, corticosteroids and ...
Hanna Heloterä, Reijo Sund, Toni Rikkonen, Kai Kaarniranta   +3 more
wiley   +1 more source

An Unusual Gastrointestinal Presentation of Sjogren's Syndrome: A Case Report. [PDF]

Clin Case Rep
Sahwan O, Jamal F, Elshaer A, Batha L, Shahin T, Pham MM.   +5 more
europepmc   +1 more source

Effects of Daratumumab Treatment on a Case of Overlapping Autoimmunity With Sjögren's Disease and Linear IgA Dermatosis

MedComm, Volume 7, Issue 9, September 2026.
Carlijn Hut, Rob J. Volkering, Gwenny M. Verstappen, Jaap A. van Doesum, Frans G. M. Kroese, Barbara Horváth, Hendrika Bootsma, Tobit D. Steinmetz   +7 more
wiley   +1 more source

Sporadic Late-onset Nemaline Myopathy Presenting with Dropped Head Syndrome and Complicated with Sjögren's Syndrome. [PDF]

Intern Med
Seki A, Seki T, Nagasako Y, Sugiyama Y, Bannai T, Yamada M, Maeda M, Kubota A, Shiio Y.   +8 more
europepmc   +1 more source

Mortality in Sjogren's syndrome

, 2008
Moutsopoulos, HM, Voulgarelis, M, Tzioufas, AG   +2 more
core